On July 1, 2014, the Company entered into a contract to lease office space in the Las Colinas Business Center in Irving, TX. Subsequent to execution of the contract, the Company revised the lease to include additional space and extend the lease term through June 30, 2023. On November 1, 2022, the Company executed an extension of leased office space to extend through November 30, 2028. This extension included an additional 3,700 square feet of space that became available for use in December 2023 and has been included in monthly rent payments accordingly.

On September 11, 2024, the Company entered into a 60-month operating lease agreement for approximately 19,076 square feet of office space in Birmingham, Alabama that is used by Asteria Health to expand its compounded bioidentical hormones manufacturing facility capabilities.

The Company recognizes operating lease costs on a straight-line basis over the lease term within selling, general and administrative expense in the unaudited condensed consolidated statements of operations and comprehensive income (loss). The following table contains a summary of the operating lease costs recognized under ASC 842 and supplemental cash flow information for leases:


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Fixed lease expense	$	193	$	171	$	385	$	297
Total lease cost	$	193	$	171	$	385	$	297

Other information:
Cash paid for amounts included in the measurement of lease liabilities	$	187	$	142	$	373	$	257
Right-of-use assets obtained in exchange for new operating lease liabilities	$	—	$	324	$	1,779	$	324

The following table summarizes the balance sheet classification of the Company’s operating leases, amounts of ROU assets and lease liabilities, the weighted average remaining lease term, and the weighted average discount rate for the Company’s operating leases:


	June 30,			December 31,
(in thousands)	2025			2024
Lease assets
Operating lease right-of-use assets	$	2,978		$	3,246
Total lease assets	$	2,978		$	3,246

Lease liabilities
Current:
Operating lease liabilities	$	557		$	523
Non-current:
Operating lease liabilities		2,601			2,890
Total lease liabilities	$	3,158		$	3,413

Weighted-average remaining lease term — operating leases (years)		5.93			6.30
Weighted-average discount rate — operating leases		7.15	%		7.20	%

The following table summarizes the payments by date for the Company’s operating lease, which is then reconciled to the total lease obligation:


As of June 30,	(in thousands)
2025 (remaining six months)	$	375
2026		774
2027		801
2028		701
2029		185
Thereafter		1,021
Total lease payments		3,857
Less: Interest		(699	)
Present value of lease liabilities	$	3,158